Specifically, the lawsuit reveals how Endo’s marketing activities resulted in Tennessee having the highest prescription rates of Opana ER in the country resulting in a wave of addiction, death, and the spread of a rare blood disorder and Hepatitis C across the state.

Read more: https://www.tn.gov/attorneygeneral/news/2019/6/12/pr19-20.html